Undermine Drug Efficacy Argument

Hard Weaken Undermine Argument

A recent study published in a renowned medical journal indicates that a new drug, Zifex, significantly reduces the symptoms of chronic migraines. The lead researcher asserts that patients who used Zifex experienced, on average, a 50% decrease in migraine occurrences within the first three months. This finding was based on a controlled trial involving 200 patients where half received Zifex and the other half received a placebo.

However, some critics argue that these results may not be relevant to the general population because the trial participants were all adults aged 25-45 who had no other health complications. They claim that applying the results to a broader demographic could be misleading.

The study's sample size of 200 patients is significantly smaller than typical clinical trials.

Some patients in the placebo group reported reduced symptoms, suggesting a placebo effect.

The study did not include patients who suffer from migraines that are resistant to medication.

The lead researcher has a financial interest in the pharmaceutical company that produces Zifex.

Other studies have shown that migraine symptoms can vary greatly among different age groups.

Hint

Submitted10.7K

Correct9.5K

% Correct89%